Ticlopidine induces embryonic development toxicity and hepatotoxicity in zebrafish by upregulating the oxidative stress signaling pathway.

Hepatotoxicity N-acetylcysteine Oxidative stress Ticlopidine Zebrafish

Journal

Ecotoxicology and environmental safety
ISSN: 1090-2414
Titre abrégé: Ecotoxicol Environ Saf
Pays: Netherlands
ID NLM: 7805381

Informations de publication

Date de publication:
31 Jul 2023
Historique:
received: 22 03 2023
revised: 26 06 2023
accepted: 17 07 2023
medline: 3 8 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: aheadofprint

Résumé

Ticlopidine exerts its anti-platelet effects mainly by antagonizing platelet p2y12 receptors. Previously, a few studies have shown that ticlopidine can induce liver injury, but the exact mechanism of hepatotoxicity remains unclear. Oxidative stress, metabolic disorders, hepatocyte apoptosis, lipid peroxidation, and inflammatory responses can all lead to hepatic liver damage, which can cause hepatotoxicity. In this study, in order to deeply explore the potential molecular mechanisms of ticlopidine -induced hepatotoxicity, we used zebrafish as a model organism to comprehensively evaluate the hepatotoxicity of ticlopidine and its associated mechanism. Three days post-fertilization, zebrafish larvae were exposed to varying concentrations (1.5, 1.75 and 2 μg/mL) of ticlopidine for 72 h, in contrast, adult zebrafish were exposed exposure to 4 μg/mL of ticlopidine for 28 days. Ticlopidine-exposed zebrafish larvae showed changes in liver morphology, shortened body length, and delayed development of the swim bladder development. Liver tissues of ticlopidine-exposed zebrafish larvae and adults stained with Hematoxylin & Eosin revealed vacuolization and increased cellular interstitial spaces in liver tissues. Furthermore, using Oil Red O and periodic acid-Schiff staining methods and evaluating different metabolic enzymes of ticlopidine-exposed zebrafish larvae and adults suggested abnormal liver metabolism and liver injury in both ticlopidine-exposed zebrafish larvae and adults. Ticlopidine also significantly elevated inflammation and oxidative stress and reduced hepatocyte proliferation. During the rescue intervention using N-acetylcysteine, we observed significant improvement in ticlopidine-induced morphological changes in the liver, shortened body length, delayed swim bladder development, and proliferation of liver tissues showed significant improvement. In conclusion, ticlopidine might inhibit normal development and liver proliferation in zebrafish by upregulation of oxidative stress levels, thus leading to embryonic developmental toxicity and hepatotoxicity. In this study, we used zebrafish as a model organism to elucidate the developmental toxicity and hepatotoxicity induced by ticlopidine upregulation of oxidative stress signaling pathway in zebrafish, providing a theoretical basis for clinical application.

Identifiants

pubmed: 37531924
pii: S0147-6513(23)00787-X
doi: 10.1016/j.ecoenv.2023.115283
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115283

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rong Xu (R)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Pengxiang Xu (P)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Haiyan Wei (H)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Yong Huang (Y)

State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330029, Jiangxi, PR China.

Xiaodan Zhu (X)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Chuanming Lin (C)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Zhimin Yan (Z)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Liuyan Xin (L)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Lin Li (L)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Weiming Lv (W)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Shuqin Zeng (S)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000 Jiangxi, PR China.

Guiyou Tian (G)

Ganzhou Key Laboratory for Drug Screening and Discovery, School of Geography and Environmental Engineering, Gannan Normal University, Ganzhou 341000 Jiangxi, PR China.

Jinze Ma (J)

Ganzhou Key Laboratory for Drug Screening and Discovery, School of Geography and Environmental Engineering, Gannan Normal University, Ganzhou 341000 Jiangxi, PR China.

Bo Cheng (B)

Ganzhou Key Laboratory for Drug Screening and Discovery, School of Geography and Environmental Engineering, Gannan Normal University, Ganzhou 341000 Jiangxi, PR China.

Huiqiang Lu (H)

Ganzhou Key Laboratory for Drug Screening and Discovery, School of Geography and Environmental Engineering, Gannan Normal University, Ganzhou 341000 Jiangxi, PR China. Electronic address: luhq2@126.com.

Yijian Chen (Y)

The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China; The Endemic Disease (Thalassemia) Clinical Research Center of Jiangxi Province, Ganzhou 341000, China. Electronic address: chenyj2005@163.com.

Classifications MeSH